C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/48 (2006.01) A61K 35/00 (2006.01) A61K 38/47 (2006.01) A61K 39/395 (2006.01) A61K 45/00 (2006.01) A61K 48/00 (2006.01) C07K 14/82 (2006.01) C07K 16/32 (2006.01) C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 5/06 (2006.01) C12N 15/09 (2006.01) C12P 21/02 (2006.01) G01N 33/15 (2006.01) G01N 33/50 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2521169
It is intended to provide a method of screening a novel compound which exhibits an anticancer activity. A screening method characterized by using serine/threonine kinase Pim-1, its partial peptide or a salt thereof.
L'invention concerne un procédé d'analyse de nouveau composé à effet anticancéreux, qui consiste à utiliser la sérine/thréonine kinase Pim-1, son peptide partiel ou un sel correspondant.
Chen Jian
Kobayashi Masanobu
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Oncorex Inc.
LandOfFree
Pharmaceutical agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1660975